Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
1. To assess whether Glucagon like peptide 2 (GLP-2) affects lipoprotein production (study
A)
2. To assess whether GLP-2 affects the release of preformed chylomicrons (study B)